Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

Thanks TV.
The focus I'd put on PSI GAD (even though intermediate results are plenty from other trials) is because I think there are only two main infliction points for a rapid rise in share price in near term - OSA and PSI GAD as they both are in phase 2a, earlier discussions have shed light on the importance of getting this right amidst the lackluster results/failure rates that generally accompanies Ph2 trials.
Nevertheless, I really wish them success. Have bought more at 45.5c today